James E. Finley
Impact in
- Developmental Neuroscience top 5%
- Anesthesia and Neurotoxicity Research
-
- Intensive Care Unit Cognitive Disorders
Papers in
- Oncology 6
- Drug Transport and Resistance Mechanisms 5
-
- Computational Drug Discovery Methods 4
- Co-authors
- Karl E. G. Richter (4 shared papers)Charles E. Nolan (4 shared papers)Joel B. Schachter (2 shared papers)Lit‐Fui Lau (2 shared papers)Emmanuel Planel (1 shared paper)Karen Duff (1 shared paper)Lili Wang (1 shared paper)Pavan Krishnamurthy (1 shared paper)
- Journals
- Bioorganic & Medicinal Chemistry Letters (2 papers)Journal of Pharmacology and Experimental Therapeutics (2 papers)Alzheimer s & Dementia (2 papers)Journal of the American Chemical Society (2 papers)The FASEB Journal (1 paper)
- Partner nations
- United StatesJapan
In The Last Decade
James E. Finley
14 papers receiving 825 citations
Peers
Comparison fields: 5 of 78
- Developmental Neuroscience 101
- Critical Care and Intensive Care Medicine 102
- Physiology 299
- Biological Psychiatry 23
- Pharmacology 127
Countries citing papers authored by James E. Finley
This map shows the geographic impact of James E. Finley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James E. Finley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James E. Finley more than expected).
Fields of papers citing papers by James E. Finley
This network shows the impact of papers produced by James E. Finley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James E. Finley. The network helps show where James E. Finley may publish in the future.
Co-authors
The 25 scholars most cited alongside James E. Finley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 336 | |
| 2 | 2018 | 143 | |
| 3 | 2006 | 120 | |
| 4 | 2017 | 90 | |
| 5 | 2010 | 47 | |
| 6 | 2021 | 30 | |
| 7 | 2010 | 29 | |
| 8 | 2010 | 14 | |
| 9 | 2010 | 14 | |
| 10 | 2008 | 13 | |
| 11 | 2017 | 13 | |
| 12 | 2015 | 9 | |
| 13 | 2020 | 6 | |
| 14 | 2025 | 2 | |
| 15 | 2017 | 0 |
About James E. Finley
James E. Finley is a scholar working on Oncology, Computational Theory and Mathematics, Physiology, Pharmacology and Molecular Biology, having authored 15 papers that have together received 866 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (5 papers), Computational Drug Discovery Methods (4 papers), Alzheimer's disease research and treatments (4 papers), Cholinesterase and Neurodegenerative Diseases (3 papers), Chemical Synthesis and Analysis (2 papers), RNA Interference and Gene Delivery (2 papers), Virus-based gene therapy research (2 papers) and CRISPR and Genetic Engineering (1 paper). The work is most often cited by research in Developmental Neuroscience (101 citations), Critical Care and Intensive Care Medicine (102 citations), Physiology (299 citations), Biological Psychiatry (23 citations) and Pharmacology (127 citations). James E. Finley has collaborated with scholars based in United States and Japan. Frequent co-authors include Karl E. G. Richter, Charles E. Nolan, Joel B. Schachter, Lit‐Fui Lau, Emmanuel Planel, Karen Duff, Lili Wang, Pavan Krishnamurthy, Mathieu Herman and Wen Yi. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Pharmacology and Experimental Therapeutics, Alzheimer s & Dementia, Journal of the American Chemical Society and The FASEB Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.